Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression

被引:25
作者
Feenstra, M [1 ]
Verdaasdonk, M [1 ]
van der Zwan, AW [1 ]
de Weger, R [1 ]
Slootweg, P [1 ]
Tilanus, M [1 ]
机构
[1] Univ Med Ctr, Dept Pathol, NL-3508 GA Utrecht, Netherlands
关键词
D O I
10.1038/labinvest.3780045
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Down-regulated human leukocyte antigen (HLA) class I expression is frequently correlated with allelic loss at 6p21.3, which is the location of the HLA coding sequence, in head and neck squamous cell carcinomas (HNSCCs). Previously, we have demonstrated loss of heterozygosity (LOH) at 6p21.3 for at least one locus in 49% of the HNSCCs using 5 microsatellite markers spanning the 4 megabase HLA region. In the present study, the detection threshold (25%) to assign LOH was addressed by laser-assisted microdissection of tumor cells from tumors containing: marginal loss. In addition, we describe high density microsatellite analysis of chromosome 6p21.3 in HNSCC with down-regulated HLA class I expression. The purpose of this study was to refine the identification of genetic alterations at 6p21.3 and to pinpoint allelic loss to individual HLA class I genes, using additional markers closely located to the HLA-A, -B, and -C loci and the,transporter associated with antigen processing (TAP) genes. LOH analysis by amplification of microsatellite markers and subsequent fluorescent detection is a rapid and sensitive technique to predict HLA class I loss phenotypes in tumors. LOH can be identified at 25% relative signal reduction. Analysis of heterogeneous tumor samples and samples containing a small amount of tumor cells is facilitated by laser-assisted microdissection of tumor cells. In addition, we showed that accurate HLA LOH analysis requires application of microsatellite markers in close proximity to HLA class I and TAP genes.
引用
收藏
页码:405 / 414
页数:10
相关论文
共 22 条
[1]   MAP OF THE HUMAN MHC [J].
CAMPBELL, RD ;
TROWSDALE, J .
IMMUNOLOGY TODAY, 1993, 14 (07) :349-352
[2]   A POLYMORPHIC DINUCLEOTIDE REPEAT IN THE 3RD INTRON OF TAP1 [J].
CARRINGTON, M ;
DEAN, M .
HUMAN MOLECULAR GENETICS, 1994, 3 (01) :218-218
[3]   Mutation in the β2m gene is not a frequent event in head and neck squamous cell carcinomas [J].
Feenstra, M ;
Rozemuller, E ;
Duran, K ;
Suy, I ;
van den Tweel, J ;
Slootweg, P ;
de Weger, R ;
Tilanus, M .
HUMAN IMMUNOLOGY, 1999, 60 (08) :697-706
[4]   HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas [J].
Feenstra, M ;
Veltkamp, M ;
van Kuik, J ;
Wiertsema, S ;
Slootweg, P ;
van den Tweel, J ;
de Weger, R ;
Tilanus, M .
TISSUE ANTIGENS, 1999, 54 (03) :235-245
[5]   LOSS OF HLA CLASS-I ANTIGENS BY MELANOMA-CELLS - MOLECULAR MECHANISMS, FUNCTIONAL-SIGNIFICANCE AND CLINICAL RELEVANCE [J].
FERRONE, S ;
MARINCOLA, FM .
IMMUNOLOGY TODAY, 1995, 16 (10) :487-494
[6]   Microsatellites in the HLA region: An overview [J].
Foissac, A ;
CrouauRoy, B ;
Faure, S ;
Thomsen, M ;
CambonThomsen, A .
TISSUE ANTIGENS, 1997, 49 (03) :197-214
[7]   Microsatellites in the HLA region: 1998 update [J].
Foissac, A ;
Cambon-Thomsen, A .
TISSUE ANTIGENS, 1998, 52 (04) :318-352
[8]   FREQUENT LOSS OF HETEROZYGOSITY ON CHROMOSOME-6 IN HUMAN OVARIAN-CARCINOMA [J].
FOULKES, WD ;
RAGOUSSIS, J ;
STAMP, GWH ;
ALLAN, GJ ;
TROWSDALE, J .
BRITISH JOURNAL OF CANCER, 1993, 67 (03) :551-559
[9]   Implications for immunosurveillance of altered HLA class I phenotypes in human tumours [J].
Garrido, F ;
RuizCabello, F ;
Cabrera, T ;
PerezVillar, JJ ;
LopezBotet, M ;
DugganKeen, M ;
Stern, PL .
IMMUNOLOGY TODAY, 1997, 18 (02) :89-95
[10]   HLA class I antigens in human tumors [J].
Garrido, F ;
Cabrera, T ;
LopezNevot, MA ;
RuizCabello, F .
ADVANCES IN CANCER RESEARCH, VOL 67, 1995, 67 :155-195